Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Legend Biotech Corporation (LEGN)
USD25.75
-1.33 (-4.91%)
US NASDAQ Healthcare Biotechnology
Address
2101 Cottontail Lane 8873
Somerset, NJ, US
Somerset, NJ, US
CEO
Ying Huang
Website
legendbiotech.com
IPO
2020-06-05
CIK 1801198 ISIN US52490G1022
Description
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD25.75
-1.33 (-4.91%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
0.35
Float Shares
178.18M
Free Float %
96.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.24% | +0.74% | +53.02% | +62.68% | -5.58% | +31.55% | +2.88% | -60.90% | -3.38% | -22.70% | -22.70% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (19 ratings, all time)
Buy
Price Targets & DCF
Current price
25.75
Low
24.00
-6.8%
Consensus
58.00
+125.2%
Median
64.00
+148.5%
High
75.00
+191.3%
Ratings Trend (MoM)
88% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 5 | 0 |
| Buy | 9 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 5 |
54.80
+112.8%
|
| Last Year | 15 |
56.40
+119.0%
|
| All Time | 30 |
69.27
+169.0%
|
Quality scores
Altman Z-Score
3.96
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+64.5% ★ Q1'26: +56.9% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-65.0% Q1'26: -5.5% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-25.8% Q1'26: -36.4% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-13.3% Q1'26: -15.4% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-29.3% Q1'26: -36.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+0.8% ★ Q1'26: -49.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-3.84× Q1'26: -3.10× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 10 Rev. Ana. 4 EPS Ana. |
Dec 2027 11 Rev. Ana. 5 EPS Ana. |
Dec 2028 11 Rev. Ana. 3 EPS Ana. |
Dec 2029 5 Rev. Ana. 1 EPS Ana. |
Dec 2030 5 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
75.00M
est: 51.63M (+45.3%)
|
68.83M
est: 72.44M (-5.0%)
|
117.01M
est: 131.97M (-11.3%)
|
285.14M
est: 455.99M (-37.5%)
|
627.24M
est: 620.51M (+1.1%)
|
1.03B
est: 1.03B (+0.1%)
|
1.43B
1.36B – 1.56B
+38.9% YoY
|
1.82B
1.61B – 2.04B
+26.9% YoY
|
2.10B
2.08B – 2.13B
+15.8% YoY
|
2.50B
2.25B – 2.77B
+18.9% YoY
|
2.74B
2.47B – 3.04B
+9.8% YoY
|
| EBITDA |
-298.16M
est: -43.17M (-590.7%)
|
-392.38M
est: -60.57M (-547.9%)
|
-416.54M
est: -110.34M (-277.5%)
|
-477.87M
est: -299.58M (-59.5%)
|
-113.16M
est: -407.66M (+72.2%)
|
-107.78M
est: -676.75M (+84.1%)
|
-939.98M
-1.03B – -893.64M
-38.9% YoY
|
-1.19B
-1.34B – -1.06B
-26.9% YoY
|
-1.38B
-1.40B – -1.36B
-15.8% YoY
|
-1.64B
-1.82B – -1.48B
-18.9% YoY
|
-1.80B
-2.00B – -1.62B
-9.8% YoY
|
| EBIT |
-308.09M
est: -43.55M (-607.4%)
|
-406.30M
est: -61.10M (-564.9%)
|
-434.93M
est: -111.32M (-290.7%)
|
-498.32M
est: -305.54M (-63.1%)
|
-136.52M
est: -415.78M (+67.2%)
|
-136.86M
est: -690.22M (+80.2%)
|
-958.70M
-1.05B – -911.44M
-38.9% YoY
|
-1.22B
-1.36B – -1.08B
-26.9% YoY
|
-1.41B
-1.43B – -1.39B
-15.8% YoY
|
-1.67B
-1.86B – -1.50B
-18.9% YoY
|
-1.84B
-2.04B – -1.65B
-9.8% YoY
|
| Net Income |
-266.37M
est: -125.25M (-112.7%)
|
-403.58M
est: -142.53M (-183.2%)
|
-446.35M
est: -133.62M (-234.1%)
|
-518.25M
est: -285.01M (-81.8%)
|
-177.03M
est: -155.98M (-13.5%)
|
-297.58M
est: -143.13M (-107.9%)
|
9.38M
-11.72M – 30.48M
+106.6% YoY
|
198.32M
114.77M – 281.88M
+2,014.7% YoY
|
288.98M
187.08M – 390.88M
+45.7% YoY
|
343.90M
298.57M – 392.57M
+19.0% YoY
|
386.64M
335.68M – 441.36M
+12.4% YoY
|
| SGA |
72.71M
est: 59.76M (+21.7%)
|
149.50M
est: 83.84M (+78.3%)
|
174.05M
est: 152.74M (+13.9%)
|
200.93M
est: 469.63M (-57.2%)
|
284.26M
est: 639.07M (-55.5%)
|
342.50M
est: 1.06B (-67.7%)
|
1.47B
1.40B – 1.61B
+38.9% YoY
|
1.87B
1.66B – 2.10B
+26.9% YoY
|
2.17B
2.14B – 2.19B
+15.8% YoY
|
2.57B
2.31B – 2.85B
+18.9% YoY
|
2.83B
2.54B – 3.13B
+9.8% YoY
|
| EPS |
-2.57
est: -1.37 (-87.6%)
|
-2.74
est: -1.56 (-75.8%)
|
-2.81
est: -1.40 (-100.7%)
|
-2.94
est: -1.57 (-87.8%)
|
-0.97
est: -0.84 (-15.5%)
|
-1.60
est: -0.79 (-102.2%)
|
0.10
-0.06 – 0.17
+112.5% YoY
|
0.92
0.62 – 1.53
+830.8% YoY
|
1.60
1.01 – 2.12
+74.6% YoY
|
1.87
1.62 – 2.13
+16.4% YoY
|
2.10
1.82 – 2.39
+12.4% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-21 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2026-04-15 | HC Wainwright & Co. | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-1.59M
OE per share TTM
0.00
Owner's Yield
-0.03%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
56.9%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
54
Total invested
82.08M
Insider transactions (90d)
0
Beneficial owners (>5%)
7
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GenScript Biotech Corporation | 174.50M | 57.10% | 174.50M | — | 174.50M | — | FI, CO | Cayman Islands | 2022-03-11 | ↗ |
| 2 | of 5 | 170.00M | 64.30% | — | — | 170.00M | — | FI, CO | — | 2021-02-16 | ↗ |
| 3 | Fangliang Zhang | 32.27M | 12.20% | 1.95M | 30.32M | 1.95M | 30.32M | IN | — | 2021-02-16 | ↗ |
| 4 | Hillhouse Investment Management, Ltd. | 30.81M | 10.30% | 30.81M | — | 30.81M | — | IA | Cayman Islands | 2021-07-12 | ↗ |
| 5 | AquaPoint L.P. | 30.32M | 11.50% | — | 30.32M | — | 30.32M | FI, PN | — | 2021-02-16 | ↗ |
| 6 | GenScript Corporation | 30.32M | 11.50% | — | 30.32M | — | 30.32M | CO | — | 2021-02-16 | ↗ |
| 7 | (1) BlackRock, Inc. | 10.53M | 5.80% | 9.89M | — | 10.53M | — | HC | Delaware | 2024-01-29 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
54
-161 vs prev Q
New positions
11
Closed positions
156
Increased
33
Reduced
11
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 1.06M +1.1M (+100.0%) | 22.97B +23.0B (+100.0%) | 1.17% +1.171 pp | 7.43% +7.427 pp | USD21.74 +0.0% | 1 qtrs NEW |
| 2 | FMR LLC | 24.27M -3.4M (-12.4%) | 527.59M -375.8M (-41.6%) | 26.90% -3.186 pp | 0.03% -0.020 pp | USD41.74 -47.9% | 23 qtrs — |
| 3 | SUVRETTA CAPITAL MANAGEMENT, LLC | 6.61M +2.8M (+73.1%) | 143.67M +19.2M (+15.4%) | 7.33% +3.180 pp | 2.94% -0.244 pp | USD28.04 -22.5% | 5 qtrs — |
| 4 | WESTFIELD CAPITAL MANAGEMENT CO LP | 6.16M +70.2K (+1.2%) | 134.02M -64.7M (-32.6%) | 6.83% +0.215 pp | 0.56% -0.276 pp | USD48.73 -55.4% | 11 qtrs — |
| 5 | HHLR ADVISORS, LTD. | 5.98M +— (+0.0%) | 130.10M -65.1M (-33.3%) | 6.63% +0.134 pp | 4.19% -0.579 pp | USD52.11 -58.3% | 23 qtrs — |
| 6 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5.93M +3.0M (+100.2%) | 128.96M +32.4M (+33.5%) | 6.58% +3.359 pp | 1.65% +0.172 pp | USD27.78 -21.7% | 5 qtrs — |
| 7 | BLACKROCK, INC. | 4.28M -217.7K (-4.8%) | 92.98M -53.6M (-36.6%) | 4.74% -0.140 pp | 0.00% -0.001 pp | USD47.47 -54.2% | 6 qtrs — |
| 8 | POINT72 ASSET MANAGEMENT, L.P. | 2.78M +2.8M (+100.0%) | 60.54M +60.5M (+100.0%) | 3.09% +3.087 pp | 0.07% +0.068 pp | USD21.74 +0.0% | 3 qtrs — |
| 9 | ARTISAN PARTNERS LIMITED PARTNERSHIP | 2.34M -206.9K (-8.1%) | 50.89M -32.2M (-38.7%) | 2.60% -0.172 pp | 0.08% -0.042 pp | USD35.09 -38.0% | 20 qtrs — |
| 10 | GOLDMAN SACHS GROUP INC | 2.17M +1.1M (+106.0%) | 47.27M +12.9M (+37.3%) | 2.41% +1.264 pp | 0.01% +0.002 pp | USD28.43 -23.5% | 21 qtrs — |
| 11 | ALLIANCEBERNSTEIN L.P. | 1.52M -115.9K (-7.1%) | 32.98M -20.3M (-38.1%) | 1.68% -0.092 pp | 0.01% -0.006 pp | USD39.95 -45.6% | 23 qtrs — |
| 12 | STATE STREET CORP | 1.52M +359.2K (+31.0%) | 32.97M -4.8M (-12.6%) | 1.68% +0.424 pp | 0.00% 0.000 pp | USD40.69 -46.6% | 21 qtrs — |
| 13 | BRAIDWELL LP | 1.30M -528.0K (-28.9%) | 28.22M -31.3M (-52.6%) | 1.44% -0.544 pp | 0.90% -0.864 pp | USD43.67 -50.2% | 13 qtrs — |
| 14 | MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 956.8K -71.6K (-7.0%) | 20.80M -12.7M (-38.0%) | 1.06% -0.056 pp | 6.31% -1.494 pp | USD40.60 -46.5% | 23 qtrs — |
| 15 | JPMORGAN CHASE & CO | 945.7K +636.1K (+205.5%) | 20.56M +10.5M (+103.6%) | 1.05% +0.712 pp | 0.00% +0.001 pp | USD26.78 -18.8% | 23 qtrs — |
| 16 | CAPITAL INTERNATIONAL INVESTORS | 941.6K +— (+0.0%) | 20.47M -10.2M (-33.3%) | 1.04% +0.021 pp | 0.00% -0.002 pp | USD45.12 -51.8% | 23 qtrs — |
| 17 | JOHNSON & JOHNSON | 814.6K +— (+0.0%) | 17.71M -8.9M (-33.3%) | 0.90% +0.018 pp | 3.19% -2.081 pp | USD50.56 -57.0% | 18 qtrs — |
| 18 | IVYROCK ASSET MANAGEMENT (HK) LTD | 804.0K -52.9K (-6.2%) | 17.48M -10.5M (-37.4%) | 0.89% -0.039 pp | 9.22% -2.789 pp | USD33.68 -35.5% | 6 qtrs — |
| 19 | MARSHALL WACE, LLP | 756.0K +738.1K (+4,129.8%) | 16.43M +15.9M (+2,719.9%) | 0.84% +0.819 pp | 0.02% +0.014 pp | USD22.28 -2.4% | 6 qtrs — |
| 20 | ARROWMARK COLORADO HOLDINGS LLC | 721.8K -216.9K (-23.1%) | 15.69M -14.9M (-48.7%) | 0.80% -0.219 pp | 0.35% -0.223 pp | USD39.25 -44.6% | 23 qtrs — |
| 21 | TWO SIGMA ADVISERS, LP | 689.6K -34.1K (-4.7%) | 14.99M -8.6M (-36.5%) | 0.76% -0.022 pp | 0.03% -0.018 pp | USD34.47 -36.9% | 6 qtrs — |
| 22 | ACADIAN ASSET MANAGEMENT LLC | 582.2K +582.2K (+100.0%) | 12.65M +12.6M (+100.0%) | 0.65% +0.645 pp | 0.02% +0.021 pp | USD21.74 +0.0% | 1 qtrs NEW |
| 23 | HUDSON BAY CAPITAL MANAGEMENT LP | 575.0K +355.0K (+161.4%) | 12.50M +5.3M (+74.2%) | 0.64% +0.399 pp | 0.04% +0.017 pp | USD25.88 -16.0% | 9 qtrs — |
| 24 | GEODE CAPITAL MANAGEMENT, LLC | 555.4K +15.4K (+2.9%) | 11.98M -5.5M (-31.4%) | 0.62% +0.029 pp | 0.00% 0.000 pp | USD46.85 -53.6% | 23 qtrs — |
| 25 | TWO SIGMA INVESTMENTS, LP | 526.1K +166.1K (+46.2%) | 11.44M -300.7K (-2.6%) | 0.58% +0.192 pp | 0.02% -0.001 pp | USD29.91 -27.3% | 6 qtrs — |
| 26 | JUMP FINANCIAL, LLC | 523.6K +120.4K (+29.9%) | 11.38M -1.8M (-13.4%) | 0.58% +0.143 pp | 0.14% -0.018 pp | USD30.49 -28.7% | 19 qtrs — |
| 27 | MORGAN STANLEY | 482.6K +51.5K (+11.9%) | 10.49M -3.6M (-25.4%) | 0.54% +0.067 pp | 0.00% 0.000 pp | USD39.84 -45.4% | 23 qtrs — |
| 28 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 480.1K -41.7K (-8.0%) | 10.44M -6.6M (-38.7%) | 0.53% -0.035 pp | 0.00% -0.002 pp | USD49.51 -56.1% | 13 qtrs — |
| 29 | SQUAREPOINT OPS LLC | 410.0K +194.7K (+90.5%) | 8.91M +1.9M (+27.0%) | 0.45% +0.221 pp | 0.01% +0.002 pp | USD31.46 -30.9% | 17 qtrs — |
| 30 | EAGLE HEALTH INVESTMENTS LP | 408.7K +408.7K (+100.0%) | 8.88M +8.9M (+100.0%) | 0.45% +0.453 pp | 1.95% +1.952 pp | USD21.74 +0.0% | 1 qtrs NEW |
| 31 | RENAISSANCE TECHNOLOGIES LLC | 402.8K -440.4K (-52.2%) | 8.76M -18.7M (-68.2%) | 0.45% -0.469 pp | 0.01% -0.023 pp | USD32.81 -33.7% | 6 qtrs — |
| 32 | SG AMERICAS SECURITIES, LLC | 371.7K +366.3K (+6,774.9%) | 8.08M +7.9M (+4,491.5%) | 0.41% +0.406 pp | 0.01% +0.010 pp | USD21.92 -0.8% | 17 qtrs — |
| 33 | BALYASNY ASSET MANAGEMENT L.P. | 343.8K +308.6K (+877.6%) | 7.47M +6.3M (+551.7%) | 0.38% +0.343 pp | 0.01% +0.008 pp | USD23.28 -6.6% | 7 qtrs — |
| 34 | EMPIRE LIFE INVESTMENTS INC. | 322.9K -2.1K (-0.6%) | 7.02M -3.6M (-33.8%) | 0.36% +0.005 pp | 0.40% -0.225 pp | USD38.14 -43.0% | 7 qtrs — |
| 35 | WALLEYE CAPITAL LLC | 299.5K +251.0K (+518.4%) | 6.51M +4.9M (+312.3%) | 0.33% +0.279 pp | 0.02% +0.014 pp | USD23.50 -7.5% | 8 qtrs — |
| 36 | BANK OF AMERICA CORP /DE/ | 287.5K -74.0K (-20.5%) | 6.25M -5.5M (-47.0%) | 0.32% -0.074 pp | 0.00% 0.000 pp | USD35.95 -39.5% | 22 qtrs — |
| 37 | NORTHERN TRUST CORP | 276.1K -11.0K (-3.8%) | 6.00M -3.4M (-35.9%) | 0.31% -0.006 pp | 0.00% 0.000 pp | USD35.07 -38.0% | 16 qtrs — |
| 38 | BARCLAYS PLC | 273.8K +192.7K (+237.7%) | 5.95M +3.3M (+125.2%) | 0.30% +0.216 pp | 0.00% +0.001 pp | USD29.48 -26.3% | 16 qtrs — |
| 39 | BNP PARIBAS ARBITRAGE, SNC | 264.9K +21.3K (+8.8%) | 5.76M -2.2M (-27.5%) | 0.29% +0.029 pp | 0.00% -0.002 pp | USD31.68 -31.4% | 5 qtrs — |
| 40 | CANDRIAM S.C.A. | 261.8K +— (+0.0%) | 5.69M -2.8M (-33.3%) | 0.29% +0.006 pp | 0.03% -0.016 pp | USD48.54 -55.2% | 14 qtrs — |
| 41 | TRIATA CAPITAL LTD | 252.6K +90.8K (+56.1%) | 5.49M +215.2K (+4.1%) | 0.28% +0.104 pp | 0.67% +0.050 pp | USD29.93 -27.4% | 3 qtrs — |
| 42 | JANE STREET GROUP, LLC | 238.1K +222.0K (+1,376.5%) | 5.18M +4.7M (+884.4%) | 0.26% +0.247 pp | 0.00% +0.001 pp | USD22.63 -3.9% | 20 qtrs — |
| 43 | LEGAL & GENERAL GROUP PLC | 227.0K -53.8K (-19.2%) | 4.93M -4.2M (-46.1%) | 0.25% -0.053 pp | 0.00% -0.001 pp | USD48.25 -54.9% | 21 qtrs — |
| 44 | IKARIAN CAPITAL, LLC | 226.9K +226.9K (+100.0%) | 4.93M +4.9M (+100.0%) | 0.25% +0.252 pp | 0.39% +0.385 pp | USD21.74 +0.0% | 1 qtrs NEW |
| 45 | UBS GROUP AG | 224.6K -786.2K (-77.8%) | 4.88M -28.1M (-85.2%) | 0.25% -0.849 pp | 0.00% -0.004 pp | USD35.62 -39.0% | 23 qtrs — |
| 46 | CASDIN CAPITAL, LLC | 215.0K +215.0K (+100.0%) | 4.67M +4.7M (+100.0%) | 0.24% +0.238 pp | 0.29% +0.290 pp | USD21.74 +0.0% | 1 qtrs NEW |
| 47 | CENTERBOOK PARTNERS LP | 213.0K +67.5K (+46.4%) | 4.63M -114.6K (-2.4%) | 0.24% +0.078 pp | 0.23% -0.008 pp | USD32.45 -33.0% | 7 qtrs — |
| 48 | WOODLINE PARTNERS LP | 205.1K +— (+0.0%) | 4.46M -2.2M (-33.3%) | 0.23% +0.005 pp | 0.02% -0.014 pp | USD44.18 -50.8% | 23 qtrs — |
| 49 | CITADEL ADVISORS LLC | 178.0K -204.8K (-53.5%) | 3.87M -8.6M (-69.0%) | 0.20% -0.218 pp | 0.00% -0.001 pp | USD36.84 -41.0% | 23 qtrs — |
| 50 | RUSSELL INVESTMENTS GROUP, LTD. | 175.8K +174.8K (+17,021.0%) | 3.79M +3.8M (+11,204.6%) | 0.19% +0.194 pp | 0.00% +0.004 pp | USD21.93 -0.9% | 16 qtrs — |
| 51 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 166.6K +396.0 (+0.2%) | 3.62M -1.8M (-33.2%) | 0.18% +0.004 pp | 0.00% -0.001 pp | USD47.61 -54.3% | 17 qtrs — |
| 52 | NEW YORK STATE COMMON RETIREMENT FUND | 163.1K +— (+0.0%) | 3.55M -1.8M (-33.3%) | 0.18% +0.004 pp | 0.00% -0.002 pp | USD36.30 -40.1% | 15 qtrs — |
| 53 | SWISS NATIONAL BANK | 161.3K -4.9K (-2.9%) | 3.51M -1.9M (-35.3%) | 0.18% -0.002 pp | 0.00% -0.001 pp | USD42.35 -48.7% | 17 qtrs — |
| 54 | DEUTSCHE BANK AG\ | 157.0K +13.3K (+9.2%) | 3.41M -1.3M (-27.2%) | 0.17% +0.018 pp | 0.00% -0.001 pp | USD47.80 -54.5% | 23 qtrs — |
| 55 | IA GLOBAL ASSET MANAGEMENT INC. | 153.2K -530.0 (-0.3%) | 3.33M -1.7M (-33.6%) | 0.17% +0.003 pp | 0.04% -0.026 pp | USD33.24 -34.6% | 5 qtrs — |
| 56 | VANGUARD GROUP INC | 149.6K +12.0K (+8.7%) | 3.25M -1.2M (-27.5%) | 0.17% +0.016 pp | 0.00% +0.000 pp | USD43.72 -50.3% | 17 qtrs — |
| 57 | PANAGORA ASSET MANAGEMENT INC | 139.9K +139.9K (+100.0%) | 3.04M +3.0M (+100.0%) | 0.16% +0.155 pp | 0.01% +0.011 pp | USD21.74 +0.0% | 1 qtrs NEW |
| 58 | EVERGREEN QUALITY FUND GP, LTD. | 122.1K -192.4K (-61.2%) | 2.65M -7.6M (-74.1%) | 0.14% -0.206 pp | 0.05% -0.175 pp | USD34.61 -37.2% | 3 qtrs — |
| 59 | PICTET ASSET MANAGEMENT HOLDING SA | 111.5K +18.0 (+0.0%) | 2.42M -1.2M (-33.3%) | 0.12% +0.003 pp | 0.00% -0.001 pp | USD47.02 -53.8% | 10 qtrs — |
| 60 | ENGINEERS GATE MANAGER LP | 106.1K +64.2K (+153.3%) | 2.31M +941.0K (+68.9%) | 0.12% +0.072 pp | 0.03% +0.012 pp | USD26.53 -18.1% | 11 qtrs — |
| 61 | CAPTION MANAGEMENT, LLC | 105.0K +105.0K (+100.0%) | 2.28M +2.3M (+100.0%) | 0.12% +0.116 pp | 0.02% +0.016 pp | USD21.74 +0.0% | 3 qtrs — |
| 62 | BANK OF NEW YORK MELLON CORP | 103.4K -18.4K (-15.1%) | 2.25M -1.7M (-43.4%) | 0.11% -0.018 pp | 0.00% 0.000 pp | USD45.85 -52.6% | 17 qtrs — |
| 63 | SEI INVESTMENTS CO | 103.0K +45.2K (+78.2%) | 2.24M +354.1K (+18.8%) | 0.11% +0.051 pp | 0.00% +0.000 pp | USD33.84 -35.8% | 19 qtrs — |
| 64 | RAIFFEISEN BANK INTERNATIONAL AG | 100.0K +25.0K (+33.3%) | 2.15M -310.8K (-12.6%) | 0.11% +0.029 pp | 0.03% -0.005 pp | USD32.05 -32.2% | 3 qtrs — |
| 65 | NUVEEN, LLC | 94.6K -1.3K (-1.4%) | 2.06M -1.1M (-34.2%) | 0.10% +0.001 pp | 0.00% 0.000 pp | USD33.93 -35.9% | 4 qtrs — |
| 66 | NEOS INVESTMENT MANAGEMENT LLC | 92.0K +37.5K (+68.7%) | 2.00M +221.8K (+12.5%) | 0.10% +0.043 pp | 0.01% -0.002 pp | USD30.97 -29.8% | 9 qtrs — |
| 67 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 91.7K +91.7K (+100.0%) | 1.99M +2.0M (+100.0%) | 0.10% +0.102 pp | 0.00% +0.001 pp | USD21.74 +0.0% | 1 qtrs NEW |
| 68 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 85.0K +24.8K (+41.2%) | 1.85M -114.9K (-5.9%) | 0.09% +0.029 pp | 0.00% 0.000 pp | USD38.18 -43.1% | 7 qtrs — |
| 69 | MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 80.4K -2.2K (-2.6%) | 1.75M -943.8K (-35.1%) | 0.09% -0.001 pp | 0.02% -0.010 pp | USD32.61 -33.3% | 2 qtrs — |
| 70 | ROYAL LONDON ASSET MANAGEMENT LTD | 79.4K +17.8K (+28.9%) | 1.73M -282.6K (-14.1%) | 0.09% +0.021 pp | 0.00% -0.001 pp | USD31.21 -30.3% | 4 qtrs — |
| 71 | MILLENNIUM MANAGEMENT LLC | 77.2K -715.3K (-90.3%) | 1.68M -24.2M (-93.5%) | 0.09% -0.775 pp | 0.00% -0.010 pp | USD38.04 -42.8% | 23 qtrs — |
| 72 | AMERIPRISE FINANCIAL INC | 75.1K -467.3K (-86.2%) | 1.63M -16.1M (-90.8%) | 0.08% -0.506 pp | 0.00% -0.004 pp | USD47.59 -54.3% | 14 qtrs — |
| 73 | CITIGROUP INC | 75.0K +27.5K (+58.0%) | 1.63M +82.2K (+5.3%) | 0.08% +0.032 pp | 0.00% +0.000 pp | USD36.90 -41.1% | 21 qtrs — |
| 74 | MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 75.1K +312.0 (+0.4%) | 1.61M -823.2K (-33.8%) | 0.08% +0.002 pp | 0.00% -0.001 pp | USD45.62 -52.3% | 19 qtrs — |
| 75 | NORDEA INVESTMENT MANAGEMENT AB | 73.6K +10.4K (+16.4%) | 1.60M -489.6K (-23.4%) | 0.08% +0.013 pp | 0.00% -0.001 pp | USD40.16 -45.9% | 8 qtrs — |
| 76 | STEMPOINT CAPITAL LP | 73.3K +73.3K (+100.0%) | 1.59M +1.6M (+100.0%) | 0.08% +0.081 pp | 0.27% +0.273 pp | USD21.74 +0.0% | 3 qtrs — |
| 77 | CAMPBELL & CO INVESTMENT ADVISER LLC | 70.6K +70.6K (+100.0%) | 1.53M +1.5M (+100.0%) | 0.08% +0.078 pp | 0.07% +0.074 pp | USD21.74 +0.0% | 3 qtrs — |
| 78 | DIADEMA PARTNERS LP | 69.0K +69.0K (+100.0%) | 1.50M +1.5M (+100.0%) | 0.08% +0.077 pp | 0.26% +0.258 pp | USD21.74 +0.0% | 1 qtrs NEW |
| 79 | SCHRODER INVESTMENT MANAGEMENT GROUP | 67.0K -61.1K (-47.7%) | 1.44M -2.8M (-65.7%) | 0.07% -0.065 pp | 0.00% -0.002 pp | USD42.59 -49.0% | 13 qtrs — |
| 80 | BOOTHBAY FUND MANAGEMENT, LLC | 65.8K +65.8K (+100.0%) | 1.43M +1.4M (+100.0%) | 0.07% +0.073 pp | 0.02% +0.021 pp | USD21.74 +0.0% | 1 qtrs NEW |
| 81 | BELLEVUE GROUP AG | 64.0K -21.0K (-24.7%) | 1.39M -1.4M (-49.8%) | 0.07% -0.021 pp | 0.03% -0.031 pp | USD46.47 -53.2% | 23 qtrs — |
| 82 | MAN GROUP PLC | 61.7K +27.9K (+82.5%) | 1.34M +239.1K (+21.7%) | 0.07% +0.032 pp | 0.00% +0.000 pp | USD28.40 -23.5% | 3 qtrs — |
| 83 | JEFFERIES FINANCIAL GROUP INC. | 60.0K +60.0K (+100.0%) | 1.30M +1.3M (+100.0%) | 0.07% +0.067 pp | 0.01% +0.007 pp | USD21.74 +0.0% | 1 qtrs NEW |
| 84 | VERITION FUND MANAGEMENT LLC | 54.3K +54.3K (+100.0%) | 1.18M +1.2M (+100.0%) | 0.06% +0.060 pp | 0.00% +0.005 pp | USD21.74 +0.0% | 1 qtrs NEW |
| 85 | TUDOR INVESTMENT CORP ET AL | 53.3K +628.0 (+1.2%) | 1.16M -558.9K (-32.5%) | 0.06% +0.002 pp | 0.00% -0.001 pp | USD33.71 -35.5% | 6 qtrs — |
| 86 | POLAR CAPITAL HOLDINGS PLC | 52.9K -1.0K (-1.9%) | 1.15M -607.8K (-34.6%) | 0.06% +0.000 pp | 0.00% -0.004 pp | USD46.50 -53.2% | 16 qtrs — |
| 87 | AVIVA PLC | 52.7K -1.5K (-2.8%) | 1.15M -622.5K (-35.2%) | 0.06% -0.001 pp | 0.00% -0.001 pp | USD47.01 -53.8% | 17 qtrs — |
| 88 | ABS DIRECT EQUITY FUND LLC | 47.2K +14.1K (+42.6%) | 1.03M -53.3K (-4.9%) | 0.05% +0.016 pp | 1.22% -0.323 pp | USD30.29 -28.2% | 4 qtrs — |
| 89 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 44.6K -32.4K (-42.1%) | 969.6K -1.5M (-61.4%) | 0.05% -0.034 pp | 0.00% 0.000 pp | USD34.08 -36.2% | 19 qtrs — |
| 90 | QUBE RESEARCH & TECHNOLOGIES LTD | 44.4K +44.4K (+100.0%) | 964.6K +964.6K (+100.0%) | 0.05% +0.049 pp | 0.00% +0.001 pp | USD21.74 +0.0% | 1 qtrs NEW |
| 91 | GUGGENHEIM CAPITAL LLC | 44.1K +8.6K (+24.4%) | 958.9K -197.4K (-17.1%) | 0.05% +0.010 pp | 0.01% -0.002 pp | USD48.32 -55.0% | 9 qtrs — |
| 92 | WALLEYE TRADING LLC | 42.4K +31.0K (+271.9%) | 921.8K +550.0K (+148.0%) | 0.05% +0.035 pp | 0.00% +0.001 pp | USD24.90 -12.7% | 5 qtrs — |
| 93 | HANDELSBANKEN FONDER AB | 42.0K +17.1K (+68.7%) | 913.0K +101.0K (+12.4%) | 0.05% +0.020 pp | 0.00% +0.000 pp | USD40.14 -45.8% | 13 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
1
Shares acquired
—
Shares disposed
9.9K
Cash buys
—
Cash sales
1.00
Net activity
-9,936
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-25 | Huang Ying | Director / Officer | S-Sale | D | Ordinary Shares | 9,936 | 8.77 | 87.1K | 247,438 | D | ↗ |
| 2026-03-18 | Zhang Fangliang | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-18 | Wang Ye | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 16 | D | ↗ |
| 2026-03-18 | Santos Carlos E | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-18 | Sanders Corazon (Corsee) D. | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 59,115 | D | ↗ |
| 2026-03-18 | Salovey Peter | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 26,766 | D | ↗ |
| 2026-03-18 | Meng Robin | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-18 | Mao Li | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 44,330 | D | ↗ |
| 2026-03-18 | Kung Gareth | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 31,486 | D | ↗ |
| 2026-03-18 | Ji Darren Xiaohui | Director | — | — | Share Option (right to buy) | 30,000 | 11.50 | 345.0K | 0 | D | ↗ |
| 2026-03-18 | Huang Ying | Director / Officer | — | — | Share Option (right to buy) | 92,134 | 14.12 | 1.30M | 0 | D | ↗ |
| 2026-03-18 | Heyman Tomas J. | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 32,734 | D | ↗ |
| 2026-03-18 | Casey Patrick John | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 54,604 | D | ↗ |
Executive team
Top executives
EBIT / Employee
-47.2K
Shares Outstanding
184.94M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Alan Bash | President of CARVYKTI® | — | male |
| Ananda Elizabeth Martin | Global Compliance Officer | — | female |
| Birk Vanderweeen | Senior Vice President of Global Manufacturing & Supply | — | male |
| Carlos Santos | Chief Financial Officer | — | male |
| Guowei Fang | President of Research & Development | — | — |
| James Pepin | General Counsel | — | male |
| Jessie Yeung | Vice President of Finance, Investor & Public Relations | — | female |
| Joanne Choi | Senior Manager of Investor Relations | — | female |
| Surabhi Verma | Manager of Investor Relations & Corporate Communications | — | — |
| Ying Huang | Chief Executive Officer & Director | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LEGN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
